Reported about 21 hours ago
Jim Cramer highlights Cardinal Health (CAH) as a standout stock amid changing market dynamics, particularly under the Trump administration. He notes that Cardinal Health's focus on domestic and specialty pharma services positions it well to benefit from potential disruptions in the pharmaceutical supply chain. Cramer includes it in his recommendations, emphasizing its strategic advantages and the broader market shifts favoring such companies.
Source: YAHOO